Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer.
Spielvogel CP, Stoiber S, Papp L, Krajnc D, Grahovac M, Gurnhofer E, Trachtova K, Bystry V, Leisser A, Jank B, Schnoell J, Kadletz L, Heiduschka G, Beyer T, Hacker M, Kenner L, Haug AR.
Spielvogel CP, et al. Among authors: leisser a.
Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):546-558. doi: 10.1007/s00259-022-05973-9. Epub 2022 Sep 26.
Eur J Nucl Med Mol Imaging. 2023.
PMID: 36161512
Free PMC article.